Discover 1,022 paid clinical trials in Stamford, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,022
Active & Responsive
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
for
Pancreatic Cancer Stage III, Pancreatic Cancer Stage IV,
Location: Norwalk CT
Sponsor: Nuvance Health
Sex: All
Age: 18+
Code: NCT04406831
Recruiting
Active & Responsive
A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus
A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
for
Pancreatic Neoplasms
Location: Norwalk CT
Sponsor: Nuvance Health
Sex: All
Age: 50 - 70+
Code: NCT03250078
Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Location: Harrison NY, Greenlawn NY, Sleepy Hollow NY, Commack NY,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07198074
Phase3, Recruiting
Active & Responsive
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
for
Recurrent Head and Neck Squamous Cell Carcinoma,
Location: Harrison NY, Trumbull CT, Commack NY, The Bronx NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT04671667
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
for
Non-small Cell Lung Cancer
Location: White Plains NY, New Haven CT, Albany NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07513376
Phase3, Recruiting
Active & Responsive
A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows
for
Moderate to Severe Glabellar Lines
Location: Westport CT, Mount Kisco NY, New York NY,
Sponsor: Ipsen
Sex: All
Age: 18+
Code: NCT07435428
Phase3, Recruiting
Active & Responsive
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
for
Major Depressive Disorder
Location: Mount Kisco NY, New York NY, Cedarhurst NY, Cromwell CT,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18+
Code: NCT06966401
Phase3, Recruiting
Active & Responsive
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
for
Stroke, Stroke, Acute, Stroke, Ischemic
Location: Valhalla NY, The Bronx NY, New York NY, New Haven CT,
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT05338697
Recruiting
Active & Responsive
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
for
Carcinoma, Non-Small-Cell Lung
Location: Valhalla NY, The Bronx NY, New York NY, New Haven CT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06623422
Phase3, Recruiting
Active & Responsive
Driving Simulator Training For Adults With Acquired Brain Injuries
for
Acquired Brain Injury
Location: Fairfield CT
Sponsor: Sacred Heart University
Sex: All
Age: 18+
Code: NCT07378592
Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
for
NASH - Nonalcoholic Steatohepatitis,
Location: Manhasset NY, New York NY, New Haven CT, Sparta NJ,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06528314
Phase3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: Manhasset NY, New York NY, Ridgewood NJ, New Haven CT,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase3, Recruiting
Active & Responsive
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
for
Extensive Stage Lung Small Cell Carcinoma,
Location: Trumbull CT, New York NY, New Haven CT, North Haven CT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06287775
Phase1, Phase2, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
for
Crohn's Disease
Location: Great Neck NY, Port Jefferson NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 16 - 70+
Code: NCT06430801
Phase3, Recruiting
Active & Responsive
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Location: Great Neck NY, Danbury CT, Bloomfield NJ, Manchester CT,
Sponsor: EyeBiotech Ltd.
Sex: All
Age: 50+
Code: NCT07496567
Phase2, Phase3, Recruiting
Active & Responsive
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
for
Cesarean Delivery, General Anesthesia
Location: Manhasset NY, Stony Brook NY, New York NY, New Haven CT,
Sponsor: Yale University
Sex: Female
Age: 15 - 55
Code: NCT06030063
Recruiting
Active & Responsive
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
for
Percutaneous Coronary Intervention,
Location: The Bronx NY, Bridgeport CT, Stamford CT, Danbury CT,
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06909565
Recruiting
Active & Responsive
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment
for
Primary Biliary Cholangitis
Location: Manhasset NY, New Haven CT, Cherry Hill NJ, Boston MA,
Sponsor: Ipsen
Sex: All
Age: 0+
Code: NCT06447168
Recruiting
Active & Responsive
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII